Highlights and Quick Summary
- Capex/Depreciation for the quarter ending December 31, 2022 was -0.03 (a -94.25% decrease compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation decreased by -91.97%
- Annual Capex/Depreciation for 2022 was -0.33 (a 107.94% increase from previous year)
- Annual Capex/Depreciation for 2021 was -0.16 (a 464.77% increase from previous year)
- Annual Capex/Depreciation for 2020 was -0.03 (a -91.44% decrease from previous year)
- Twelve month Capex/Depreciation ending December 31, 2022 was -0.33 (a -10.35% decrease compared to previous quarter)
- Twelve month trailing Capex/Depreciation increased by 23.55% year-over-year
Trailing Capex/Depreciation for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -0.33 | -0.37 | -0.33 | -0.27 |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Precigen, Inc.
Most recent Capex/Depreciationof PGEN including historical data for past 10 years.Interactive Chart of Capex/Depreciation of Precigen, Inc.
Precigen, Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -0.03 | -0.46 | -0.38 | -0.33 | -0.33 |
| 2021 | -0.34 | -0.29 | -0.13 | 0.15 | -0.16 |
| 2020 | 0.49 | -0.11 | -0.06 | -0.34 | -0.03 |
| 2019 | -0.05 | -0.66 | -5.61 | -1.37 | -0.33 |
| 2018 | -0.88 | -0.42 | -0.38 | -1.11 | -0.59 |
| 2017 | -0.92 | -2.39 | 10.28 | -0.67 | -1.55 |
| 2016 | -0.55 | -1.72 | -0.19 | -0.15 | -0.37 |
| 2015 | -0.79 | -0.08 | -0.16 | 0.02 | 0.25 |
| 2014 | 0.03 | -0.04 | -0.02 | 0.15 | -0.28 |
| 2013 | 0.1 | 0.0 | 0.1 | -0.01 | 0.42 |
| 2012 | -0.02 | -0.03 | 0.58 | – | -0.52 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology